when were glp 1 agonists approved for weight loss Comparing GLP-type therapies in those without diabetes. Two glucagon-like peptide-1 receptor (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults A clinician's perspective 📝 GLP-1

Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: A randomised, placebo-controlled and active comparator-controlled phase 2 trial

Supporting natural GH pulses during deep sleep phases has been shown to improve slow-wave sleep and sleep efficiency within 24 weeks in research models

In the gut specifically, KPV is absorbed through a dedicated intestinal transporter (PepT1), allowing it to calm inflammation directly inside epithelial cells

Key Studies: A 2002 study found that ME/CFS patients with lower blood levels of ALCAR experienced more severe fatigue

I always do IV with them